Shares of MELA Sciences traded down 6.83% during mid-day trading on Wednesday, hitting $2.73. MELA Sciences has a one year low of $1.75 and a one year high of $6.96. The company’s market cap is $82.8 million.
Separately, analysts at Needham & Company reiterated a “buy” rating on shares of MELA Sciences in a research note to investors on Friday, May 4th.
MELA Sciences, Inc., formerly Electro-Optical Sciences, Inc., is a medical device company focused on the design, development and commercialization of a non-invasive, point-of-care (in the doctor’s office) instrument to assist in the early diagnosis of melanoma.